Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.
about
Purification to homogeneity and the N-terminal sequence of human leukotriene C4 synthase: a homodimeric glutathione S-transferase composed of 18-kDa subunitsMolecular cloning and expression of human leukotriene-C4 synthaseIntracellular delivery of nanoparticles of an antiasthmatic drug.The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood-brain barrier: a positron emission tomography study.Oral pharmacokinetics and food interaction of the leukotriene D4 receptor antagonist verlukast.
P2860
Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.
@ast
Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.
@en
type
label
Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.
@ast
Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.
@en
prefLabel
Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.
@ast
Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.
@en
P2860
P1476
Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.
@en
P2093
Margolskee DJ
P2860
P304
P356
10.1111/J.1749-6632.1991.TB37972.X
P407
P577
1991-01-01T00:00:00Z